FINAL DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Organon
Defendants provided these overwhelmingly positive statements to investors while, at the same time, disseminating materially false and misleading statements and/or concealing material adverse facts
Share
Faruqi & Faruqi is a leading national securities law firm with offices in New York, Pennsylvania, California and Georgia. The firm has recovered hundreds of millions of dollars for investors since its founding in 1995. See www.faruqilaw.com.
Defendants provided investors with material information concerning Organon's prioritization of its capital allocation strategy through regular, quarterly dividends. Defendants' statements included, among other things, reassurance that capital allocation through the aforementioned dividends was a '#1 capital allocation priority' and that Organon was committed to consistent deployment of capital. Defendants provided these overwhelmingly positive statements to investors while, at the same time, disseminating materially false and misleading statements and/or concealing material adverse facts concerning the true state of the Company's priorities, particularly, related to capital allocation through quarterly dividends. Notably, Defendants concealed the high priority of Organon's debt reduction strategy following the Company's acquisition of Dermavant, resulting in a 70% decrease for the regular quarterly dividend. Such statements absent these material facts caused Plaintiff and other shareholders to purchase Organon's securities at artificially inflated prices.
Investors and analysts again reacted promptly to Organon's revelations. The price of Organon's common stock declined dramatically. From a closing market price of $12.93 per share on April 30, 2025, Organon's stock price fell to $9.45 per share on May 1, 2025, a decline of more than 27% in the span of just a single day.
The court-appointed lead plaintiff is the investor with the largest financial interest in the relief sought by the class who is adequate and typical of class members who directs and oversees the litigation on behalf of the putative class. Any member of the putative class may move the Court to serve as lead plaintiff through counsel of their choice, or may choose to do nothing and remain an absent class member. Your ability to share in any recovery is not affected by the decision to serve as a lead plaintiff or not.
Faruqi & Faruqi, LLP also encourages anyone with information regarding Organon's conduct to contact the firm, including whistleblowers, former employees, shareholders and others.
To learn more about the Organon & Co. class action, go to www.faruqilaw.com/OGN or call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310).
Follow us for updates on LinkedIn, on X, or on Facebook.
Attorney Advertising. The law firm responsible for this advertisement is Faruqi & Faruqi, LLP (www.faruqilaw.com). Prior results do not guarantee or predict a similar outcome with respect to any future matter. We welcome the opportunity to discuss your particular case. All communications will be treated in a confidential manner.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
25 minutes ago
- Yahoo
Exxon Mobil Second Quarter 2025 Earnings: Beats Expectations
Exxon Mobil (NYSE:XOM) Second Quarter 2025 Results Key Financial Results Revenue: US$80.0b (down 12% from 2Q 2024). Net income: US$7.08b (down 23% from 2Q 2024). Profit margin: 8.8% (down from 10% in 2Q 2024). The decrease in margin was driven by lower revenue. EPS: US$1.64 (down from US$2.14 in 2Q 2024). Trump has pledged to "unleash" American oil and gas and these 15 US stocks have developments that are poised to benefit. All figures shown in the chart above are for the trailing 12 month (TTM) period Exxon Mobil Revenues and Earnings Beat Expectations Revenue exceeded analyst estimates by 1.3%. Earnings per share (EPS) also surpassed analyst estimates by 4.5%. Looking ahead, revenue is forecast to stay flat during the next 3 years compared to a 3.7% growth forecast for the Oil and Gas industry in the US. Performance of the American Oil and Gas industry. The company's share price is broadly unchanged from a week ago. Balance Sheet Analysis Just as investors must consider earnings, it is also important to take into account the strength of a company's balance sheet. We've done some analysis and you can see our take on Exxon Mobil's balance sheet. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Yahoo
2 hours ago
- Yahoo
MSA Safety (MSA) Reports Q2: Everything You Need To Know Ahead Of Earnings
Safety equipment manufacturer MSA Safety (NYSE:MSA) will be reporting results this Monday afternoon. Here's what to look for. MSA Safety beat analysts' revenue expectations by 5% last quarter, reporting revenues of $421.3 million, up 1.9% year on year. It was an exceptional quarter for the company, with an impressive beat of analysts' EPS estimates. Is MSA Safety a buy or sell going into earnings? Read our full analysis here, it's free. This quarter, analysts are expecting MSA Safety's revenue to decline 3.2% year on year to $447.8 million, a reversal from the 3.4% increase it recorded in the same quarter last year. Adjusted earnings are expected to come in at $1.76 per share. The majority of analysts covering the company have reconfirmed their estimates over the last 30 days, suggesting they anticipate the business to stay the course heading into earnings. MSA Safety has missed Wall Street's revenue estimates three times over the last two years. Looking at MSA Safety's peers in the business services & supplies segment, some have already reported their Q2 results, giving us a hint as to what we can expect. HNI delivered year-on-year revenue growth of 7%, beating analysts' expectations by 3.2%, and MillerKnoll reported revenues up 8.2%, topping estimates by 5.3%. HNI's stock price was unchanged after the resultswhile MillerKnoll was up 12.2%. Read our full analysis of HNI's results here and MillerKnoll's results here. Questions about potential tariffs and corporate tax changes have caused much volatility in 2025. While some of the business services & supplies stocks have shown solid performance in this choppy environment, the group has generally underperformed, with share prices down 4.4% on average over the last month. MSA Safety is up 2.2% during the same time and is heading into earnings with an average analyst price target of $182.20 (compared to the current share price of $175.23). Unless you've been living under a rock, it should be obvious by now that generative AI is going to have a huge impact on how large corporations do business. While Nvidia and AMD are trading close to all-time highs, we prefer a lesser-known (but still profitable) semiconductor stock benefiting from the rise of AI. Click here to access our free report on our favorite semiconductor growth story. StockStory is growing and hiring equity analyst and marketing roles. Are you a 0 to 1 builder passionate about the markets and AI? See the open roles here. Sign in to access your portfolio
Yahoo
2 hours ago
- Yahoo
Icahn Enterprises (IEP) Q2 Earnings Report Preview: What To Look For
Holding company and industrial conglomerate Icahn (NYSE:IEP) will be reporting results this Monday before the bell. Here's what to expect. Icahn Enterprises missed analysts' revenue expectations by 29% last quarter, reporting revenues of $1.87 billion, down 24.6% year on year. It was a disappointing quarter for the company, with a significant miss of analysts' EPS estimates. Is Icahn Enterprises a buy or sell going into earnings? Read our full analysis here, it's free. This quarter, analysts are expecting Icahn Enterprises's revenue to grow 8.5% year on year to $2.39 billion, a reversal from the 13.7% decrease it recorded in the same quarter last year. The majority of analysts covering the company have reconfirmed their estimates over the last 30 days, suggesting they anticipate the business to stay the course heading into earnings. Icahn Enterprises has missed Wall Street's revenue estimates five times over the last two years. Looking at Icahn Enterprises's peers in the general industrial machinery segment, some have already reported their Q2 results, giving us a hint as to what we can expect. Luxfer delivered year-on-year revenue growth of 4.3%, beating analysts' expectations by 5.9%, and GE Aerospace reported revenues up 23.4%, topping estimates by 6.5%. Luxfer's stock price was unchanged after the resultswhile GE Aerospace was down 1.1%. Read our full analysis of Luxfer's results here and GE Aerospace's results here. Investors in the general industrial machinery segment have had steady hands going into earnings, with share prices flat over the last month. Icahn Enterprises is up 6.3% during the same time and is heading into earnings with an average analyst price target of $12 (compared to the current share price of $9.00). Today's young investors likely haven't read the timeless lessons in Gorilla Game: Picking Winners In High Technology because it was written more than 20 years ago when Microsoft and Apple were first establishing their supremacy. But if we apply the same principles, then enterprise software stocks leveraging their own generative AI capabilities may well be the Gorillas of the future. So, in that spirit, we are excited to present our Special Free Report on a profitable, fast-growing enterprise software stock that is already riding the automation wave and looking to catch the generative AI next. StockStory is growing and hiring equity analyst and marketing roles. Are you a 0 to 1 builder passionate about the markets and AI? See the open roles here. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
